Tirzepatide

Tirzepatide is a dual incretin receptor agonist designed to target both GLP-1 and GIP receptors, supporting research and treatment related to metabolic health, blood sugar regulation, and weight management. It is widely recognized for its role in helping regulate appetite, improve insulin sensitivity, and support healthy energy balance. In clinical and research settings, Tirzepatide has shown significant potential for promoting weight reduction and improving glucose control through its long-acting peptide mechanism. Its multi-pathway activity has made it an important focus in obesity and metabolic research.